Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16951 - 16975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ciglitazone	Experimental	ANGPTL4	51129	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of ANGPTL4 mRNA	19p13.2	A21647
Ciglitazone	Experimental	APOL1	8542	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of APOL1 mRNA	22q12.3	A21647
Ciglitazone	Experimental	APOM	55937	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of APOM mRNA	6p21.33	A21647
Ciglitazone	Experimental	AQP3	360	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AQP3 mRNA	9p13.3	A21647
Ciglitazone	Experimental	AQP3	360	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of AQP3 mRNA	9p13.3	A21647
Ciglitazone	Experimental	ARHGEF2	9181	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ARHGEF2 mRNA	1q22	A21647
Ciglitazone	Experimental	ATF7IP2	80063	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ATF7IP2 mRNA	16p13.2-p13.13	A21647
Ciglitazone	Experimental	BCL6	604	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BCL6 mRNA	3q27.3	A21647
Ciglitazone	Experimental	BDH1	622	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BDH1 mRNA	3q29	A21647
Ciglitazone	Experimental	BHMT	635	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BHMT mRNA	5q14.1	A21647
Ciglitazone	Experimental	BLVRB	645	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BLVRB mRNA	19q13.2	A21647
Ciglitazone	Experimental	CASP3	836	upregulated	ciglitazone results in increased expression of CASP3 mRNA	4q35.1	A21648
Ciglitazone	Experimental	CAT	847	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CAT mRNA	11p13	A21647
Ciglitazone	Experimental	CCL14	6358	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL14 mRNA	17q12	A21647
Ciglitazone	Experimental	CCL14	6358	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of CCL14 mRNA	17q12	A21647
Ciglitazone	Experimental	CCL15	6359	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL15 mRNA	17q12	A21647
Ciglitazone	Experimental	CCL15	6359	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of CCL15 mRNA	17q12	A21647
Ciglitazone	Experimental	CCL20	6364	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL20 mRNA	2q36.3	A21647
Ciglitazone	Experimental	CCL20	6364	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of CCL20 mRNA	2q36.3	A21647
Ciglitazone	Experimental	CDH1	999	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CDH1 mRNA	16q22.1	A21647
Ciglitazone	Experimental	CDH1	999	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of CDH1 mRNA	16q22.1	A21647
Ciglitazone	Experimental	CEBPD	1052	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of CEBPD mRNA	8q11.21	A21647
Ciglitazone	Experimental	CES1	1066	downregulated	ciglitazone results in decreased expression of CES1 mRNA	16q12.2	A21649
Ciglitazone	Experimental	CHMP5	51510	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of CHMP5 mRNA	9p13.3	A21647
Ciglitazone	Experimental	CIDEC	63924	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CIDEC mRNA	3p25.3	A21647

Displaying entries 16951 - 16975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability